Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region
Muscle & Nerve · 2025
DOI: 10.1002/mus.28301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Ellie Jacoby und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Neuromuscular Section, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Prealbumin, Amyloid Neuropathies, Familial, Polymorphism, Single Nucleotide. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Introduction/Aims Hereditary transthyretin amyloidosis (ATTRv) is a genetic condition caused by pathogenic variants in the transthyretin ( TTR ) gene resulting in multisystem amyloid deposition, especially in peripheral nerve and heart. Information on the prevalence of ATTRv in the United States is limited. The objective of this study was to understand the prevalence and genetic ancestry in the Val142Ile population in a large regional US population.
Methods
Colorado Center for Personalized Medicine (CCPM) biobank collects specimens from consenting adults seen throughout the University of Colorado Health System, a large tertiary healthcare system within the Rocky Mountain Region (RMR). Single nucleotide polymorphism (SNP) array genotyping and whole exome sequencing (WES) were performed for genetic research. Prevalence of TTR variants was studied.
Results
A total of 73,346 participants had genetic testing; 151 (0.21%) individuals had a pathogenic or likely pathogenic TTR variant. The most common variant was Val142Ile, making up 82.61% of TTR variants found. Over four percent of people with African non‐Hispanic ancestry had a Val142Ile variant.
Discussion
The most common TTR variant in our study was Val142Ile, the most common variant in the United States (US). Similar to other US‐based studies, affected individuals were predominantly of African, non‐Hispanic ancestry. The availability of treatments for symptomatic ATTRv patients raises opportunities and challenges for biobanks as the identification of at‐risk individuals places pressure on highly specialized centers and providers to see patients for screening and follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Department, Neuromuscular Section, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Colorado Center for Personalized Medicine, Aurora, Colorado, USA.
- Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Ellie Jacoby
Zitieren
APA
Jacoby, E., Quan, D., Todd, E., Shortt, J., Smith, H., Rafaels, N., Crooks, K., & CCPM biobank Author Banner list (2025). Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region. Muscle & Nerve. https://doi.org/10.1002/mus.28301
Vancouver
Jacoby E, Quan D, Todd E, Shortt J, Smith H, Rafaels N, et al. Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region. Muscle & Nerve. 2025. doi:10.1002/mus.28301
BibTeX
@article{Jacoby2025,
author = {Jacoby, Ellie and Quan, Dianna and Todd, Emily and Shortt, Jonathan and Smith, Harry and Rafaels, Nicholas and Crooks, Kristy and CCPM biobank Author Banner list, CCPM biobank Author Banner list},
title = {Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region},
journal = {Muscle & Nerve},
year = {2025},
doi = {10.1002/mus.28301}
}
EUVIMED